In a previous study, VWF:Ag/ADAMTS13:AC ratio was used as a biomarker of treatment response in HCC patients before the initiation of HAIC treatment, and ROC curves were used to evaluate predictive efficiency, yielding an AUC of 0.715 (Takaya et al. 2020). This evidence concerns the gene ADAMTS13 and hepatocellular carcinoma.